
Fund+ is a Belgian venture capital firm based in Leuven that invests in innovative European Life Sciences companies, primarily in therapeutics, diagnostics, and medical devices. It is an open-ended fund for long-term equity investment with a focus on Belgium, targeting companies at Series A or B stage that have reached proof of concept.
46% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (2 deals in the last 12 months vs 3 prior). Average disclosed round size is $27.4M (across 16 rounds with reported amounts).
Portfolio
38
Fund Size
—
Top Stage
Series A
Last 12 Mo
2
Team
Looking for someone who isn't listed here?
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
52 investments
| Company | Round |
|---|---|
| Series C | |
| TTubulis GmbHOct 2025 | Series C |
| Seed | |
| Series A | |
| Series A | |
| MMindPeak GmbHSep 2024 · $15.3M | Series A |
| Seed | |
| CConfo TherapeuticsJan 2024 | Series B |
| Seed | |
| Series A | |
| Unknown | |
| Unknown | |
| Series B | |
| TTubulis GmbHMay 2022 | Series B |
| Series B | |
| TTargED Biopharmaceuticals B.V.Feb 2022 | Series A |
| TTarged BiopharmaceuticalsJan 2022 | Series A |
| TTubulis GmbHJan 2022 | Series B |
| TTargED Biopharmaceuticals B.V.Jan 2022 | Series A |
| Series B | |
| Unknown | |
| Unknown | |
| Seed | |
| Series A | |
| Series B |
Page 1 of 3
Looking for the people behind these companies?
Top Co-Investors
Andera Partners8 shared
EQT Life Sciences8 shared
High-Tech Gründerfonds7 shared
Bpifrance7 shared
Kurma Partners7 shared
PMV7 shared
coparion6 shared
Bayern Kapital5 shared
Seventure Partners5 shared
INKEF Capital5 shared
Hadean Ventures5 shared
Idinvest5 shared
Ysios Capital5 shared
Wellington Management4 shared
Sunstone Life Science Ventures4 shared
Seroba Life Sciences4 shared
Omnes Capital4 shared
The Invus Group, LLC4 shared
VIB4 shared
Last updated: 18 November 2026